Efficacy and Cost-Benefit Analysis of Plerixafor Plus Filgrastim Based on a Risk Adaptive Approach for Autologous Peripheral Blood Hematopoietic Progenitor Cell Collection

✍ Scribed by P. Vishnu; V. Roy; A. Paulsen; A.C. Zubair

• Book ID: 116282093
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 80 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.142